🇺🇸 FDA
Company

Relay

Relay Therapeutics

RLAY biotech USA

Quick answer

Relay is a biotech company (RLAY) headquartered in CAMBRIDGE, MA, USA with 4 tracked pipeline programs.

Pipeline (4)

project

RLY-2608

PIK3CA Mutation

Phase 3 · small_molecule · active

2 trials project

RLY-2608

PIK3CA-Related Overgrowth Spectrum (PROS)

Phase 2 · small_molecule · active

1 trials project

RLY-5836

PIK3CA Mutation

Phase 1 · small_molecule · completed

1 trials project

RLY-8161

NRAS Mutation

Phase 1 · small_molecule · active

1 trials

Patents (8)

patent

US 12331056

SHP2 phosphatase inhibitors and methods of use thereof

Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12219327

Substituted isoindolines as PI3K-alpha inhibitors

Expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12152034

FGFR inhibitors and methods of making and using the same

Expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12138263

Pyrazolo[3,4-b]pyrazine SHP2 phosphatase inhibitors and methods of use thereof

Expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12084447

SHP2 phosphatase inhibitors and methods of use thereof

Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11890281

SHP2 phosphatase inhibitors and methods of making and using the same

Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11780845

FGFR inhibitors and methods of use thereof

Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11701354

Pyrazolo[3,4-b]pyrazine derivatives as SHP2 phosphatase inhibitors

Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)